ERBB2 and neoplasm: Ezrin stabilizes the multiprotein complex consisting of HER2, plasma membrane Ca2+-ATPase 2 (PMCA2), NHERF1, and HSP90 at the specialized membrane domain, which results in membrane retention of HER2 contributing to tumor progression [92].